Incidence of Intravascular (IV) Injection During Trigeminal Nerve Blocks

Launched by SEOUL NATIONAL UNIVERSITY · Jul 8, 2020

Keywords

ClinConnect Summary

This clinical trial is looking at how often a specific issue, called intravascular injection, happens during a medical procedure known as a trigeminal nerve block. This procedure is often performed on patients who suffer from conditions like trigeminal neuralgia, facial pain, postherpetic neuralgia, or cluster headaches. The trial is currently recruiting participants and is open to individuals aged 18 to 80 who are scheduled for this nerve block treatment.

To participate, patients should not be pregnant, have any bleeding disorders, or have certain infections or allergies. If you join the study, you can expect to undergo the usual procedures for a trigeminal nerve block, and the researchers will monitor how often the intravascular injection occurs. This study aims to improve our understanding of this procedure and help make it safer for patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The patients who scheduled to undergo trigeminal nerve block due to the facial pain
• Exclusion Criteria:
• • Refusal of the patient
• • Pregnancy
• • Coagulopathy
• • Local or systemic infection
• • Allergy to injectate
• • Anatomical deformation of the skull